CVR 39889846Entrepreneurial company (IVS)Forskning og eksperimentel udvikling indenfor bioteknologi (721100)CharlottenlundFounded 25 Sep 2018
CVR holds no employment figures for this company.
CVR holds no annual report for this company.
Dandex has recorded no changes to this company since it began following the register.
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about LOXiPharm IVS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexHELLERUNG ApSCVR 25382455, 10% to under 15% of capital and votes, until 13 Jul 2021
Janine Terra Erleruntil 8 Oct 2020
No current owner is registered.
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
CVR 2538245510% to under 15% of capital and votes25 Sep 2018 to 13 Jul 2021
CVR lists no current officers for this company.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
25 Sep 2018 to 6 Nov 2026.
Each registered value from the day it took effect, newest first.
From CVR, read 6 Nov 2026. Text such as the signing rule and purpose is shown as registered.
6 registrations, newest first. As published by Erhvervsstyrelsen, in Danish, with people's street addresses cut to postcode and city.
Binavne:
LOXiPharm Medical IVS UNDER KONKURS
Konkursbehandlingen afsluttet 13.07.2021, virksomheden opløst
Binavne:
LOXiPharm Medical IVS UNDER TVANGSOPLØSNING
Konkursdekret afsagt 10.12.2020 af Sø- og Handelsrettens Skifteretsafdeling
Likvidatorer:
Fratrådte:
Bo Lauritzen, den 10.12.2020.
Revision:
Binavne:
LOXiPharm Medical IVS UNDER TVANGSOPLØSNING
Likvidatorer:
Tiltrådte:
Sø- og Handelsrettens Skifteretsafdeling har udnævnt følgende likvidatorer: Bo Lauritzen, 1265 København K, den 24.11.2020.
Virksomheden tegnes af en likvidator
Virksomhedens kreditorer opfordres til at anmelde deres krav til likvidator. Krav skal anmeldes senest tre måneder fra dags dato.
Anmodning om opløsning, jf. selskabslovens § 225 sendt til Sø- og Handelsrettens Skifteretsafdeling den 08.10.2020
Direktion:
Fratrådte:
Janine Terra Erler, den 08.10.2020.
Ny adresse: Ordrupvej 132C, 1. mf, 2920 Charlottenlund
Ny kommune: Gentofte
Binavne: LOXiPharm Medical IVS.
Stiftelsesdato: 25.09.2018.
Seneste vedtægtsdato: 25.09.2018.
Kapital:
kr. 1,00.
Kapitalklasser: Nej
Indbetalingsmåde: Indbetalt kontant kr. 1,00 til kurs 100,00, fuldt indbetalt.
Stiftere:
Pier Giorgio Amendola, den 25.09.2018, Janine Terra Erler, den 25.09.2018, Raphael Peter Reuten, den 25.09.2018, CVR-NR. 25382455 HELLERUNG ApS, c/o Beierholm, Knud Højgaards Vej 9, 2860 Søborg, den 25.09.2018.
Direktion:
Janine Terra Erler, den 25.09.2018.
Virksomheden tegnes af en direktør alene..
Første regnskabsår:
25.09.2018 - 31.12.2019.
Regnskabsår:
01.01 - 31.12.
Formål:
The company's purpose is to develop therapies against cancer and fibrosis.
1 registered in CVR.
P-number 1023985531Ordrupvej 132, 2920 Charlottenlund
